Y. Ueda, “Effects and Safety of Linagliptin as an Add-on Therapy in Advanced-Stage Diabetic Nephropathy Patients Taking Renin–Angiotensin–Aldosterone System Blockers”, dti, vol. 10, no. 1, Sep. 2016.